Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

MJ Gleeson operating profits seen lower

(Sharecast News) - Housebuilding company MJ Gleeson warned on Tuesday that the pace of the housing market recovery has not been sufficient to offset the cumulative impact of "a number of headwinds" to gross margins, weighing on FY operating profits. MJ Gleeson pointed to headwinds such as increased build costs, flat selling prices, the continued use of incentives and several bulk sale transactions.

As a result, MJ Gleeson said gross margins in its Gleeson Homes unit were now forecast to be approximately 1% lower than previously expected.

The London-listed group anticipates operating profits coming in roughly 15% to 20% lower than current expectations, even after including profit contributions from the disposal of one of Gleeson Homes' land holdings in East Yorkshire.

"Looking ahead, a number of factors will continue to impact Gleeson Homes into FY26, including planning delays which will see the business selling from fewer sites than previously forecast. Gleeson Homes' gross margin in FY26 is also expected to be circa 1% lower than market expectations," added MJ Gleeson.

As of 0840 BST, MJ Gleeson shares had sunk 22.63% to 399.24p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.